Breathing Circuits Market - Global Forecast To 2029
| 出版社 | MarketsandMarkets |
| 出版年月 | 2024年9月 |
| ページ数 | 282 |
| 図表数 | 348 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
Report Overview
The breathing circuits market is expected to grow to USD 2.16 billion by 2029 from an estimated USD 1.57 billion in 2024, at a CAGR of 6.5% during the forecast period.
呼吸回路市場は、2024年の推定15億7,000万米ドルから2029年までに21億6,000万米ドルに成長すると予想されており、予測期間中のCAGRは6.5%です。
Improvements in breathing circuit technology is one of the major drivers of the market. Within the past couple of years, new initiatives and efforts taken towards enhancing safety, comfort, and efficiency-oriented development have resulted in increasingly sophisticated and efficient forms of breathing circuits. For instance, breathing circuits that feature inbuilt humidification, antimicrobial filters, and advanced ergonomic designs have added to a much greater effect in delivering respiratory support while reducing infections and discomfort. Moreover, with advanced materials used in production, breathing circuits become more biocompatible and resistant. Such technological advancements by different key players will lead to increased adoption of breathing circuits, thus driving the market growth in the coming years.
“Adult patients segment accounted for the highest growth rate in the breathing circuits market, by patient type, during the forecast period.”
Based on patient type, the breathing circuits market is bifurcated into adult patients and pediatric and neonatal patients. The adult patients segment expected to have the highest CAGR during the forecast period. The growth in this patient segment is driven by the increasing rate of adult surgical interventions, especially complex and high-risk cases needing breathing circuits for anesthesia and respiratory support. Furthermore, the aging population and rising prevalence of chronic respiratory disorders, such as COPD, asthma, and sleep apnea, are often associated with the use of advanced breathing circuits, especially in surgical procedures, which further support this segment’s growth. Moreover, sedentary life, poor diet, and smoking act also as major contributory factors to such conditions and hence increase the demand for advanced breathing circuits in managing and treating respiratory diseases in adults.
“Dual-limb Breathing Circuits segment is expected to have the fastest growth rate in the breathing circuits market, by circuit type, during the forecast period.”
The breathing circuits market is segmented into single-limb breathing circuits and dual-limb breathing circuits, based on circuit type. Dual-limb breathing circuits are projected to account for the highest CAGR during the forecast period. Dual-limb breathing circuits are likely to witness a huge demand, as they offer numerous advantages for critical and specialized medical applications. One major factor is that they provide two distinct and controlled channels for inhalation and exhalation, which increases the efficiency of ventilation by preventing rebreathing of exhaled carbon dioxide. This would be very important in ICUs and OTs, where it would be important to correct management of gases in order to ensure patient safety and optimum respiratory support. Another advantage of dual-limb circuits is that accessories, like humidifiers, filters, and monitoring equipment, can be fitted to facilitate appropriate and comprehensive care for the patient. Added to this is the fact that these circuits can adapt to different patients and different medical interventions that further increase their applicability in healthcare.
“Asia Pacific: The fastest-growing region in breathing circuits market.”
The worldwide market for breathing circuits is categorized into North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries. Notably, the Asia Pacific region is anticipated to experience the most substantial growth in the forecast period. The Asia Pacific region, a hub for medical tourism, is rapidly emerging as a leader in the market for medical procedures and devices. Growth in this market is driven by several factors, that include the increased investment and modernization in the health care infrastructure, which improves the availability as well as the quality of medical services. Rising patient population and occurrences of chronic respiratory diseases further fuel the demand. Moreover, high economic growth in developing countries, including China, India, and others, has led to increases in health care expenditures and the demand for more modern medical devices, including breathing circuits.
The break-up of the profile of primary participants in the breathing circuits market:
- By Company Type: Tier 1 – 40%, Tier 2 – 30%, and Tier 3 – 30%
- By Designation: C-level – 27%, D-level – 18%, and Others – 55%
- By Region: North America – 51%, Europe – 21%, Asia Pacific – 18%, Latin America – 6%, and Middle East & Africa- 4%
The key players in this market are Drägerwerk AG & Co. KGaA (Germany), Medtronic (Ireland), Cardinal Health (US), Fisher & Paykel Healthcare Limited (New Zealand), ResMed (US), Ambu A/S (Denmark), GE Healthcare (US), ICU Medical, Inc. (US), Koninklijke Philips N.V. (Netherlands), Hamilton Medical (Switzerland), Medline Industries, LP (US), Forca Healthcare (India), Braun & Co. Limited (UK), Inspiration Healthcare Group PLC (UK), Besmed Health Business Corp. (Taiwan), Eakin Healthcare (UK), BOMIMED (Canada), Flexicare (Group) Limited (UK), Bio-Med Devices (US), Airlife (US), Mercury Medical (US), Intersurgical Ltd (UK), Fairmont Medical Products Pty Ltd. (Australia), Breas Medical AB (Sweden), and GPC Medical Ltd. (India).
Research Coverage:
This research report categorizes the breathing circuits market by usage (disposable breathing circuits and reusable breathing circuits), by patient type (adult patients and pediatric and neonatal patients), by circuit type (single-limb breathing circuits and dual-limb breathing circuits), by application (anesthesia, respiratory dysfunction, and other applications), by end user (hospitals, ambulatory surgical centers, clinics, and other end users), and region (North America, Europe, Asia Pacific, Latin America, the Middle East & Africa and GCC countries). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges influencing the growth of the breathing circuits market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, key strategies, acquisitions, and agreements. New product & service launches, and recent developments associated with the breathing circuits market. Competitive analysis of upcoming startups in the breathing circuits market ecosystem is covered in this report.
Reasons to buy this report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall breathing circuits market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
- Analysis of key drivers (growing prevalence of respiratory diseases, rising number of emergency cases globally, increasing number of surgical procedures, and technological advancements), opportunities (Growth opportunities in emerging economies), restraints (Unfavorable reimbursement scenario and high risk of infection associated with reusable breathing circuits), and challenges (environmental concerns related to single-use and non-biodegradable breathing circuits) influencing the growth of the breathing circuits market.
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the breathing circuits market.
- Market Development: Comprehensive information about lucrative markets – the report analyses the breathing circuits market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the breathing circuits market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings of leading players like Drägerwerk AG & Co. KGaA (Germany), Medtronic (Ireland), Cardinal Health (US), Fisher & Paykel Healthcare Limited (New Zealand), and ResMed (US).
Table of Contents
1 INTRODUCTION 26
1.1 STUDY OBJECTIVES 26
1.2 MARKET DEFINITION 26
1.3 STUDY SCOPE 27
1.3.1 SEGMENTS CONSIDERED 27
1.3.2 INCLUSIONS AND EXCLUSIONS 28
1.3.3 YEARS CONSIDERED 28
1.3.4 CURRENCY CONSIDERED 29
1.4 STAKEHOLDERS 29
2 RESEARCH METHODOLOGY 30
2.1 RESEARCH DATA 30
2.1.1 SECONDARY DATA 31
2.1.1.1 Key secondary sources 31
2.1.1.2 Key data from secondary sources 32
2.1.1.3 Objectives of secondary research 32
2.1.2 PRIMARY DATA 33
2.1.2.1 Key primary sources 33
2.1.2.2 Key data from primary sources 34
2.1.2.3 Key industry insights 35
2.1.2.4 Breakdown of primaries 35
2.2 MARKET SIZE ESTIMATION 36
2.2.1 BOTTOM-UP APPROACH 37
2.2.1.1 Company revenue estimation approach 37
2.2.1.2 Company presentations and primary interviews 37
2.2.1.3 Growth forecast 38
2.2.1.4 CAGR projections 38
2.2.2 TOP-DOWN APPROACH 38
2.3 DATA TRIANGULATION 40
2.4 MARKET SHARE ANALYSIS 41
2.5 STUDY ASSUMPTIONS 41
2.6 GROWTH RATE ASSUMPTIONS 41
2.7 RESEARCH LIMITATIONS 42
2.8 RISK ASSESSMENT 42
3 EXECUTIVE SUMMARY 43
4 PREMIUM INSIGHTS 48
4.1 BREATHING CIRCUITS MARKET OVERVIEW 48
4.2 BREATHING CIRCUITS MARKET, BY USAGE, 2024 VS. 2029 48
4.3 BREATHING CIRCUITS MARKET, BY PATIENT TYPE, 2024 VS. 2029 49
4.4 BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE, 2024 VS. 2029 49
4.5 BREATHING CIRCUITS MARKET, BY APPLICATION, 2024 VS. 2029 50
4.6 BREATHING CIRCUITS MARKET, BY END USER, 2024 VS. 2029 50
4.7 BREATHING CIRCUITS MARKET: REGIONAL GROWTH OPPORTUNITIES 51
5 MARKET OVERVIEW 52
5.1 INTRODUCTION 52
5.2 MARKET DYNAMICS 52
5.2.1 DRIVERS 53
5.2.1.1 Growing prevalence of respiratory diseases 53
5.2.1.2 Rising number of emergency cases globally 54
5.2.1.3 Increasing number of surgical procedures 55
5.2.1.4 Technological advancements 56
5.2.2 RESTRAINTS 57
5.2.2.1 Unfavorable reimbursement scenario 57
5.2.2.2 High risk of infection associated with reusable breathing circuits 57
5.2.3 OPPORTUNITIES 58
5.2.3.1 Growth opportunities in emerging economies 58
5.2.4 CHALLENGES 58
5.2.4.1 Environmental concerns related to single-use and non-biodegradable breathing circuits 58
5.3 PRICING ANALYSIS 59
5.4 PATENT ANALYSIS 62
5.4.1 LIST OF MAJOR PATENTS 63
5.5 VALUE CHAIN ANALYSIS 64
5.6 SUPPLY CHAIN ANALYSIS 65
5.7 TRADE ANALYSIS 66
5.7.1 IMPORT DATA (HS CODE 901920) 66
5.7.2 EXPORT DATA (HS CODE 901920) 67
5.8 ECOSYSTEM ANALYSIS 67
5.8.1 ROLE IN ECOSYSTEM 68
5.9 PORTER’S FIVE FORCES ANALYSIS 69
5.9.1 THREAT OF NEW ENTRANTS 70
5.9.2 THREAT OF SUBSTITUTES 70
5.9.3 BARGAINING POWER OF BUYERS 70
5.9.4 BARGAINING POWER OF SUPPLIERS 71
5.9.5 INTENSITY OF COMPETITIVE RIVALRY 71
5.10 KEY STAKEHOLDERS AND BUYING CRITERIA 71
5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS 71
5.10.2 KEY BUYING CRITERIA 72
5.11 REGULATORY ANALYSIS 73
5.11.1 REGULATORY LANDSCAPE 73
5.11.1.1 North America 73
5.11.1.1.1 US 73
5.11.1.1.2 Canada 74
5.11.1.2 Europe 74
5.11.1.3 Asia Pacific 74
5.11.1.3.1 China 74
5.11.1.3.2 Japan 75
5.11.1.3.3 India 76
5.11.1.4 Latin America 76
5.11.1.4.1 Brazil 76
5.11.1.4.2 Mexico 76
5.11.1.5 Middle East 77
5.11.1.6 Africa 77
5.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77
5.12 TECHNOLOGY ANALYSIS 79
5.12.1 KEY TECHNOLOGIES 79
5.12.1.1 Single-limb breathing circuits 79
5.12.2 COMPLEMENTARY TECHNOLOGIES 80
5.12.2.1 Dual-limb breathing circuits 80
5.12.3 ADJACENT TECHNOLOGIES 80
5.12.3.1 Low dead space circuits 80
5.13 KEY CONFERENCES AND EVENTS IN 2024–2025 81
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 82
5.15 INVESTMENT AND FUNDING SCENARIO 82
5.16 IMPACT OF AI/GEN AI ON BREATHING CIRCUITS MARKET 84
5.16.1 KEY USE CASES 85
6 BREATHING CIRCUITS MARKET, BY USAGE 86
6.1 INTRODUCTION 87
6.2 DISPOSABLE BREATHING CIRCUITS 87
6.2.1 GROWING EMPHASIS ON INFECTION CONTROL AND PATIENT SAFETY TO DRIVE MARKET 87
6.3 REUSABLE BREATHING CIRCUITS 91
6.3.1 COST-EFFECTIVENESS AND REDUCED ENVIRONMENTAL FOOTPRINT TO PROPEL MARKET GROWTH 91
7 BREATHING CIRCUITS MARKET, BY PATIENT TYPE 95
7.1 INTRODUCTION 96
7.2 ADULT PATIENTS 96
7.2.1 INCREASING SURGICAL PROCEDURES AND GROWING PREVALENCE OF LIFESTYLE-RELATED DISEASES TO BOOST MARKET GROWTH 96
7.3 PEDIATRIC AND NEONATAL PATIENTS 101
7.3.1 INCREASING TIMELY INTERVENTION AND TREATMENT IN PEDIATRIC CARE TO FUEL MARKET GROWTH 101
8 BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE 105
8.1 INTRODUCTION 106
8.2 SINGLE-LIMB BREATHING CIRCUITS 106
8.2.1 SIMPLE DESIGN AND EASE OF USE TO AID MARKET GROWTH 106
8.3 DUAL-LIMB BREATHING CIRCUITS 110
8.3.1 HIGH DEMAND FOR ADVANCED VENTILATION SOLUTIONS AND INCREASED PATIENT COMFORT TO SPUR MARKET GROWTH 110
9 BREATHING CIRCUITS MARKET, BY APPLICATION 114
9.1 INTRODUCTION 115
9.2 ANESTHESIA 115
9.2.1 INCREASING NUMBER OF SURGERIES AND MINIMALLY INVASIVE PROCEDURES TO AUGMENT MARKET GROWTH 115
9.3 RESPIRATORY DYSFUNCTION 120
9.3.1 RISING PREVALENCE OF CHRONIC PULMONARY DISEASES AND SLEEP APNEA TO FUEL MARKET GROWTH 120
9.4 OTHER APPLICATIONS 124
10 BREATHING CIRCUITS MARKET, BY END USER 128
10.1 INTRODUCTION 129
10.2 HOSPITALS 129
10.2.1 INCREASING NUMBER OF HOSPITALS AND RISING GOVERNMENT HEALTHCARE INVESTMENTS TO SUPPORT MARKET GROWTH 129
10.3 AMBULATORY SURGERY CENTERS 133
10.3.1 FOCUS ON COST-EFFECTIVE AND IMPROVED PATIENT EXPERIENCE TO DRIVE MARKET 133
10.4 CLINICS 136
10.4.1 RISING PREVALENCE OF TARGET DISEASES TO SUPPORT MARKET GROWTH 136
10.5 OTHER END USERS 139
11 BREATHING CIRCUITS MARKET, BY REGION 143
11.1 INTRODUCTION 144
11.2 NORTH AMERICA 144
11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 148
11.2.2 US 148
11.2.2.1 US to dominate North American breathing circuits market during study period 148
11.2.3 CANADA 151
11.2.3.1 High geriatric population and improved healthcare infrastructure to propel market growth 151
11.3 EUROPE 154
11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 157
11.3.2 GERMANY 158
11.3.2.1 High healthcare spending and favorable government policies to favor market growth 158
11.3.3 FRANCE 160
11.3.3.1 Advanced healthcare system and increased number of surgeries to augment market growth 160
11.3.4 UK 163
11.3.4.1 Rising geriatric population and increasing initiatives by public and private organizations to aid market growth 163
11.3.5 ITALY 165
11.3.5.1 Improved quality of medical care and high geriatric population to spur market growth 165
11.3.6 SPAIN 168
11.3.6.1 Increased incidence of chronic diseases and improved healthcare infrastructure to drive demand 168
11.3.7 REST OF EUROPE 170
11.4 ASIA PACIFIC 173
11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 177
11.4.2 JAPAN 177
11.4.2.1 Presence of universal healthcare reimbursement policy and high geriatric population to drive market 177
11.4.3 CHINA 180
11.4.3.1 Increasing number of hospitals and growing public access to modern healthcare to fuel market growth 180
11.4.4 INDIA 183
11.4.4.1 Large patient population and developed healthcare sector to boost market growth 183
11.4.5 AUSTRALIA 185
11.4.5.1 Increasing prevalence of chronic respiratory diseases to fuel market 185
11.4.6 SOUTH KOREA 188
11.4.6.1 Increasing private hospitals and growing medical tourism to support market growth 188
11.4.7 REST OF ASIA PACIFIC 190
11.5 LATIN AMERICA 192
11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 195
11.5.2 BRAZIL 196
11.5.2.1 Developed public health systems and improved healthcare infrastructure to favor market growth 196
11.5.3 MEXICO 198
11.5.3.1 Modern healthcare infrastructure and availability of advanced surgical techniques to augment market growth 198
11.5.4 REST OF LATIN AMERICA 200
11.6 MIDDLE EAST & AFRICA 202
11.6.1 DEVELOPED HEALTHCARE INFRASTRUCTURE AND FAVORABLE GOVERNMENT HEALTH POLICIES TO PROPEL MARKET 202
11.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 205
11.7 GCC COUNTRIES 205
11.7.1 INCREASING GOVERNMENT HEALTHCARE SPENDING AND GROWING MEDICAL TOURISM TO AID MARKET GROWTH 205
11.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES 208
12 COMPETITIVE LANDSCAPE 209
12.1 INTRODUCTION 209
12.2 KEY PLAYER STRATEGY/RIGHT TO WIN 209
12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN BREATHING CIRCUITS MARKET 209
12.3 REVENUE ANALYSIS, 2021–2023 211
12.4 MARKET SHARE ANALYSIS, 2023 212
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 214
12.5.1 STARS 214
12.5.2 EMERGING LEADERS 214
12.5.3 PERVASIVE PLAYERS 214
12.5.4 PARTICIPANTS 214
12.5.5 COMPANY FOOTPRINT, KEY PLAYERS, 2023 216
12.5.5.1 Company footprint 216
12.5.5.2 Usage footprint 216
12.5.5.3 Application footprint 217
12.5.5.4 Region footprint 218
12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 218
12.6.1 PROGRESSIVE COMPANIES 218
12.6.2 RESPONSIVE COMPANIES 219
12.6.3 DYNAMIC COMPANIES 219
12.6.4 STARTING BLOCKS 219
12.6.5 COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS, 2023 220
12.7 COMPANY VALUATION AND FINANCIAL METRICS 221
12.8 BRAND/PRODUCT COMPARISON 222
12.9 COMPETITIVE SCENARIO 223
12.9.1 PRODUCT LAUNCHES 223
12.9.2 DEALS 224
13 COMPANY PROFILES 225
13.1 KEY PLAYERS 225
13.1.1 DRÄGERWERK AG & CO. KGAA 225
13.1.1.1 Business overview 225
13.1.1.2 Products offered 227
13.1.1.3 Recent developments 228
13.1.1.3.1 Product launches 228
13.1.1.3.2 Deals 228
13.1.1.4 MnM view 228
13.1.1.4.1 Key strengths 228
13.1.1.4.2 Strategic choices 229
13.1.1.4.3 Weaknesses and competitive threats 229
13.1.2 MEDTRONIC 230
13.1.2.1 Business overview 230
13.1.2.2 Products offered 231
13.1.2.3 Recent developments 232
13.1.2.3.1 Deals 232
13.1.2.4 MnM view 232
13.1.2.4.1 Key strengths 232
13.1.2.4.2 Strategic choices 233
13.1.2.4.3 Weaknesses and competitive threats 233
13.1.3 CARDINAL HEALTH 234
13.1.3.1 Business overview 234
13.1.3.2 Products offered 235
13.1.3.3 Recent developments 236
13.1.3.3.1 Expansions 236
13.1.3.4 MnM view 236
13.1.3.4.1 Key strengths 236
13.1.3.4.2 Strategic choices 236
13.1.3.4.3 Weaknesses and competitive threats 237
13.1.4 FISHER & PAYKEL HEALTHCARE LIMITED 238
13.1.4.1 Business overview 238
13.1.4.2 Products offered 239
13.1.4.3 Recent developments 240
13.1.4.3.1 Expansions 240
13.1.4.4 MnM view 240
13.1.4.4.1 Key strengths 240
13.1.4.4.2 Strategic choices 240
13.1.4.4.3 Weaknesses and competitive threats 240
13.1.5 RESMED 241
13.1.5.1 Business overview 241
13.1.5.2 Products offered 242
13.1.5.3 Recent developments 243
13.1.5.3.1 Expansions 243
13.1.5.4 MnM view 243
13.1.5.4.1 Key strengths 243
13.1.5.4.2 Strategic choices 243
13.1.5.4.3 Weaknesses and competitive threats 243
13.1.6 AMBU A/S 244
13.1.6.1 Business overview 244
13.1.6.2 Products offered 246
13.1.6.3 Recent developments 246
13.1.6.3.1 Expansions 246
13.1.7 GE HEALTHCARE 247
13.1.7.1 Business overview 247
13.1.7.2 Products offered 248
13.1.7.3 Recent developments 249
13.1.7.3.1 Deals 249
13.1.7.3.2 Expansions 249
13.1.8 KONINKLIJKE PHILIPS N.V. 250
13.1.8.1 Business overview 250
13.1.8.2 Products offered 251
13.1.8.3 Recent developments 252
13.1.8.3.1 Deals 252
13.1.9 ICU MEDICAL, INC. 253
13.1.9.1 Business overview 253
13.1.9.2 Products offered 255
13.1.9.3 Recent developments 255
13.1.9.3.1 Deals 255
13.1.10 HAMILTON MEDICAL 256
13.1.10.1 Business overview 256
13.1.10.2 Products offered 256
13.1.11 MEDLINE INDUSTRIES, LP 257
13.1.11.1 Business overview 257
13.1.11.2 Products offered 257
13.1.11.3 Recent developments 258
13.1.11.3.1 Deals 258
13.1.11.3.2 Expansions 259
13.2 OTHER PLAYERS 260
13.2.1 FORCA HEALTHCARE 260
13.2.2 BRAUN & CO. LIMITED 261
13.2.3 INSPIRATION HEALTHCARE GROUP PLC 262
13.2.4 BESMED HEALTH BUSINESS CORP. 263
13.2.5 EAKIN HEALTHCARE 264
13.2.6 BOMIMED 265
13.2.7 FLEXICARE (GROUP) LIMITED 266
13.2.8 BIO-MED DEVICES 267
13.2.9 AIRLIFE 268
13.2.10 MERCURY MEDICAL 269
13.2.11 INTERSURGICAL LTD. 270
13.2.12 FAIRMONT MEDICAL PRODUCTS PTY LTD. 271
13.2.13 BREAS MEDICAL AB 272
13.2.14 GPC MEDICAL LTD. 273
14 APPENDIX 274
14.1 DISCUSSION GUIDE 274
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 278
14.3 CUSTOMIZATION OPTIONS 280
14.4 RELATED REPORTS 280
14.5 AUTHOR DETAILS 281
LIST OF TABLES
TABLE 1 BREATHING CIRCUITS MARKET: INCLUSIONS AND EXCLUSIONS 28
TABLE 2 BREATHING CIRCUITS MARKET: KEY DATA FROM PRIMARY SOURCES 34
TABLE 3 BREATHING CIRCUITS MARKET: RISK ASSESSMENT 42
TABLE 4 NUMBER OF SURGERIES PERFORMED GLOBALLY, BY COUNTRY, 2022 56
TABLE 5 INDICATIVE SELLING PRICING OF BREATHING CIRCUITS, BY PRODUCT, 2022–2024 59
TABLE 6 INDICATIVE SELLING PRICE OF BREATHING CIRCUITS, BY REGION, 2022–2024 60
TABLE 7 BREATHING CIRCUITS MARKET: LIST OF MAJOR PATENTS, 2022–2023 63
TABLE 8 IMPORT DATA FOR HS CODE 901920, BY COUNTRY, 2019–2023 (USD MILLION) 66
TABLE 9 EXPORT DATA FOR HS CODE 901920, BY COUNTRY, 2019–2023 (USD MILLION) 67
TABLE 10 BREATHING CIRCUITS MARKET: ROLE IN ECOSYSTEM 68
TABLE 11 BREATHING CIRCUITS MARKET: IMPACT OF PORTER’S FIVE FORCES 70
TABLE 12 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF BREATHING CIRCUITS (%) 72
TABLE 13 KEY BUYING CRITERIA FOR BREATHING CIRCUITS, BY CIRCUIT TYPE 72
TABLE 14 CLASSIFICATION OF MEDICAL DEVICES BY US FDA 74
TABLE 15 CHINA: MEDICAL DEVICES CLASSIFICATION BY NATIONAL MEDICAL PRODUCTS ADMINISTRATION (NMPA) 75
TABLE 16 JAPAN: CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODIES 75
TABLE 17 NORTH AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77
TABLE 18 EUROPE: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
TABLE 19 ASIA PACIFIC: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
TABLE 20 LATIN AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79
TABLE 21 REST OF THE WORLD: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79
TABLE 22 BREATHING CIRCUITS MARKET: DETAILED LIST OF KEY CONFERENCES AND EVENTS, JANUARY 2024–DECEMBER 2025 81
TABLE 23 BREATHING CIRCUITS MARKET, BY USAGE, 2022–2029 (USD MILLION) 87
TABLE 24 KEY PRODUCTS IN DISPOSABLE BREATHING CIRCUITS MARKET 88
TABLE 25 DISPOSABLE BREATHING CIRCUITS MARKET, BY REGION,
2022–2029 (USD MILLION) 89
TABLE 26 NORTH AMERICA: DISPOSABLE BREATHING CIRCUITS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 89
TABLE 27 EUROPE: DISPOSABLE BREATHING CIRCUITS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 90
TABLE 28 ASIA PACIFIC: DISPOSABLE BREATHING CIRCUITS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 90
TABLE 29 LATIN AMERICA: DISPOSABLE BREATHING CIRCUITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 91
TABLE 30 KEY PRODUCTS IN REUSABLE BREATHING CIRCUITS MARKET 92
TABLE 31 REUSABLE BREATHING CIRCUITS MARKET, BY REGION, 2022–2029 (USD MILLION) 92
TABLE 32 NORTH AMERICA: REUSABLE BREATHING CIRCUITS MARKET, BY COUNTRY
2022–2029 (USD MILLION) 93
TABLE 33 EUROPE: REUSABLE BREATHING CIRCUITS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 93
TABLE 34 ASIA PACIFIC: REUSABLE BREATHING CIRCUITS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 94
TABLE 35 LATIN AMERICA: REUSABLE BREATHING CIRCUITS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 94
TABLE 36 BREATHING CIRCUITS MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION) 96
TABLE 37 KEY PRODUCTS IN BREATHING CIRCUITS MARKET FOR ADULT PATIENTS 98
TABLE 38 BREATHING CIRCUITS MARKET FOR ADULT PATIENTS, BY REGION,
2022–2029 (USD MILLION) 99
TABLE 39 NORTH AMERICA: BREATHING CIRCUITS MARKET FOR ADULT PATIENTS,
BY COUNTRY 2022–2029 (USD MILLION) 99
TABLE 40 EUROPE: BREATHING CIRCUITS MARKET FOR ADULT PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION) 100
TABLE 41 ASIA PACIFIC: BREATHING CIRCUITS MARKET FOR ADULT PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION) 100
TABLE 42 LATIN AMERICA: BREATHING CIRCUITS MARKET FOR ADULT PATIENTS,
BY COUNTRY, 2022–2029 (USD MILLION) 101
TABLE 43 KEY PRODUCTS IN BREATHING CIRCUITS MARKET FOR PEDIATRIC AND NEONATAL PATIENTS 102
TABLE 44 BREATHING CIRCUITS MARKET FOR PEDIATRIC AND NEONATAL PATIENTS,
BY REGION, 2022–2029 (USD MILLION) 102
TABLE 45 NORTH AMERICA: BREATHING CIRCUITS MARKET FOR PEDIATRIC AND NEONATAL PATIENTS, BY COUNTRY 2022–2029 (USD MILLION) 103
TABLE 46 EUROPE: BREATHING CIRCUITS MARKET FOR PEDIATRIC AND NEONATAL PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION) 103
TABLE 47 ASIA PACIFIC: BREATHING CIRCUITS MARKET FOR PEDIATRIC AND NEONATAL PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION) 104
TABLE 48 LATIN AMERICA: BREATHING CIRCUITS MARKET FOR PEDIATRIC AND NEONATAL PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION) 104
TABLE 49 BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE, 2022–2029 (USD MILLION) 106
TABLE 50 KEY PRODUCTS IN SINGLE-LIMB BREATHING CIRCUITS MARKET 107
TABLE 51 SINGLE-LIMB BREATHING CIRCUITS MARKET, BY REGION,
2022–2029 (USD MILLION) 108
TABLE 52 NORTH AMERICA: SINGLE-LIMB BREATHING CIRCUITS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 108
TABLE 53 EUROPE: SINGLE-LIMB BREATHING CIRCUITS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 109
TABLE 54 ASIA PACIFIC: SINGLE-LIMB BREATHING CIRCUITS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 109
TABLE 55 LATIN AMERICA: SINGLE-LIMB BREATHING CIRCUITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 110
TABLE 56 KEY PRODUCTS IN DUAL-LIMB BREATHING CIRCUITS MARKET 111
TABLE 57 DUAL-LIMB BREATHING CIRCUITS MARKET, BY REGION,
2022–2029 (USD MILLION) 111
TABLE 58 NORTH AMERICA: DUAL-LIMB BREATHING CIRCUITS MARKET, BY COUNTRY
2022–2029 (USD MILLION) 112
TABLE 59 EUROPE: DUAL-LIMB BREATHING CIRCUITS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 112
TABLE 60 ASIA PACIFIC: DUAL-LIMB BREATHING CIRCUITS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 113
TABLE 61 LATIN AMERICA: DUAL-LIMB BREATHING CIRCUITS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 113
TABLE 62 BREATHING CIRCUITS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 115
TABLE 63 KEY PRODUCTS IN BREATHING CIRCUITS MARKET FOR ANESTHESIA 117
TABLE 64 BREATHING CIRCUITS MARKET FOR ANESTHESIA, BY REGION,
2022–2029 (USD MILLION) 118
TABLE 65 NORTH AMERICA: BREATHING CIRCUITS MARKET FOR ANESTHESIA, BY COUNTRY 2022–2029 (USD MILLION) 118
TABLE 66 EUROPE: BREATHING CIRCUITS MARKET FOR ANESTHESIA, BY COUNTRY,
2022–2029 (USD MILLION) 119
TABLE 67 ASIA PACIFIC: BREATHING CIRCUITS MARKET FOR ANESTHESIA, BY COUNTRY, 2022–2029 (USD MILLION) 119
TABLE 68 LATIN AMERICA: BREATHING CIRCUITS MARKET FOR ANESTHESIA, BY COUNTRY, 2022–2029 (USD MILLION) 120
TABLE 69 KEY PRODUCTS IN BREATHING CIRCUITS MARKET FOR RESPIRATORY DYSFUNCTION 121
TABLE 70 BREATHING CIRCUITS MARKET FOR RESPIRATORY DYSFUNCTION, BY REGION, 2022–2029 (USD MILLION) 122
TABLE 71 NORTH AMERICA: BREATHING CIRCUITS MARKET FOR RESPIRATORY DYSFUNCTION, BY COUNTRY, 2022–2029 (USD MILLION) 122
TABLE 72 EUROPE: BREATHING CIRCUITS MARKET FOR RESPIRATORY DYSFUNCTION,
BY COUNTRY, 2022–2029 (USD MILLION) 123
TABLE 73 ASIA PACIFIC: BREATHING CIRCUITS MARKET FOR RESPIRATORY DYSFUNCTION, BY COUNTRY, 2022–2029 (USD MILLION) 123
TABLE 74 LATIN AMERICA: BREATHING CIRCUITS MARKET FOR RESPIRATORY DYSFUNCTION, BY COUNTRY, 2022–2029 (USD MILLION) 124
TABLE 75 KEY PRODUCTS IN BREATHING CIRCUITS MARKET FOR OTHER APPLICATIONS 125
TABLE 76 BREATHING CIRCUITS MARKET FOR OTHER APPLICATIONS, BY REGION,
2022–2029 (USD MILLION) 125
TABLE 77 NORTH AMERICA: BREATHING CIRCUITS MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2022–2029 (USD MILLION) 125
TABLE 78 EUROPE: BREATHING CIRCUITS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 126
TABLE 79 ASIA PACIFIC: BREATHING CIRCUITS MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2022–2029 (USD MILLION) 126
TABLE 80 LATIN AMERICA: BREATHING CIRCUITS MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2022–2029 (USD MILLION) 127
TABLE 81 BREATHING CIRCUITS MARKET, BY END USER, 2022–2029 (USD MILLION) 129
TABLE 82 BREATHING CIRCUITS MARKET FOR HOSPITALS, BY REGION,
2022–2029 (USD MILLION) 131
TABLE 83 NORTH AMERICA: BREATHING CIRCUITS MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION) 131
TABLE 84 EUROPE: BREATHING CIRCUITS MARKET FOR HOSPITALS, BY COUNTRY,
2022–2029 (USD MILLION) 132
TABLE 85 ASIA PACIFIC: BREATHING CIRCUITS MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION) 132
TABLE 86 LATIN AMERICA: BREATHING CIRCUITS MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION) 133
TABLE 87 BREATHING CIRCUITS MARKET FOR AMBULATORY SURGERY CENTERS,
BY REGION, 2022–2029 (USD MILLION) 134
TABLE 88 NORTH AMERICA: BREATHING CIRCUITS MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY 2022–2029 (USD MILLION) 134
TABLE 89 EUROPE: BREATHING CIRCUITS MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2022–2029 (USD MILLION) 135
TABLE 90 ASIA PACIFIC: BREATHING CIRCUITS MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2022–2029 (USD MILLION) 135
TABLE 91 LATIN AMERICA: BREATHING CIRCUITS MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2022–2029 (USD MILLION) 136
TABLE 92 BREATHING CIRCUITS MARKET FOR CLINICS, BY REGION,
2022–2029 (USD MILLION) 137
TABLE 93 NORTH AMERICA: BREATHING CIRCUITS MARKET FOR CLINICS, BY COUNTRY 2022–2029 (USD MILLION) 137
TABLE 94 EUROPE: BREATHING CIRCUITS MARKET FOR CLINICS, BY COUNTRY,
2022–2029 (USD MILLION) 138
TABLE 95 ASIA PACIFIC: BREATHING CIRCUITS MARKET FOR CLINICS, BY COUNTRY,
2022–2029 (USD MILLION) 138
TABLE 96 LATIN AMERICA: BREATHING CIRCUITS MARKET FOR CLINICS, BY COUNTRY, 2022–2029 (USD MILLION) 139
TABLE 97 BREATHING CIRCUITS MARKET FOR OTHER END USERS, BY REGION,
2022–2029 (USD MILLION) 140
TABLE 98 NORTH AMERICA: BREATHING CIRCUITS MARKET FOR OTHER END USERS,
BY COUNTRY 2022–2029 (USD MILLION) 140
TABLE 99 EUROPE: BREATHING CIRCUITS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION) 141
TABLE 100 ASIA PACIFIC: BREATHING CIRCUITS MARKET FOR OTHER END USERS,
BY COUNTRY, 2022–2029 (USD MILLION) 141
TABLE 101 LATIN AMERICA: BREATHING CIRCUITS MARKET FOR OTHER END USERS,
BY COUNTRY, 2022–2029 (USD MILLION) 142
TABLE 102 BREATHING CIRCUITS MARKET, BY REGION, 2022–2029 (USD MILLION) 144
TABLE 103 NORTH AMERICA: BREATHING CIRCUITS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 146
TABLE 104 NORTH AMERICA: BREATHING CIRCUITS MARKET, BY USAGE,
2022–2029 (USD MILLION) 146
TABLE 105 NORTH AMERICA: BREATHING CIRCUITS MARKET, BY PATIENT TYPE,
2022–2029 (USD MILLION) 146
TABLE 106 NORTH AMERICA: BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE,
2022–2029 (USD MILLION) 147
TABLE 107 NORTH AMERICA: BREATHING CIRCUITS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 147
TABLE 108 NORTH AMERICA: BREATHING CIRCUITS MARKET, BY END USER,
2022–2029 (USD MILLION) 147
TABLE 109 NORTH AMERICA: MACROINDICATORS FOR BREATHING CIRCUITS MARKET 148
TABLE 110 US: BREATHING CIRCUITS MARKET, BY USAGE, 2022–2029 (USD MILLION) 150
TABLE 111 US: BREATHING CIRCUITS MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION) 150
TABLE 112 US: BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE, 2022–2029 (USD MILLION) 150
TABLE 113 US: BREATHING CIRCUITS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 151
TABLE 114 US: BREATHING CIRCUITS MARKET, BY END USER, 2022–2029 (USD MILLION) 151
TABLE 115 CANADA: NUMBER OF SURGICAL PROCEDURES PERFORMED, 2022 152
TABLE 116 CANADA: BREATHING CIRCUITS MARKET, BY USAGE, 2022–2029 (USD MILLION) 152
TABLE 117 CANADA: BREATHING CIRCUITS MARKET, BY PATIENT TYPE,
2022–2029 (USD MILLION) 153
TABLE 118 CANADA: BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE,
2022–2029 (USD MILLION) 153
TABLE 119 CANADA: BREATHING CIRCUITS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 153
TABLE 120 CANADA: BREATHING CIRCUITS MARKET, BY END USER,
2022–2029 (USD MILLION) 154
TABLE 121 EUROPE: BREATHING CIRCUITS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 155
TABLE 122 EUROPE: BREATHING CIRCUITS MARKET, BY USAGE, 2022–2029 (USD MILLION) 155
TABLE 123 EUROPE: BREATHING CIRCUITS MARKET, BY PATIENT TYPE,
2022–2029 (USD MILLION) 156
TABLE 124 EUROPE: BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE,
2022–2029 (USD MILLION) 156
TABLE 125 EUROPE: BREATHING CIRCUITS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 156
TABLE 126 EUROPE: BREATHING CIRCUITS MARKET, BY END USER,
2022–2029 (USD MILLION) 157
TABLE 127 EUROPE: MACROINDICATORS FOR BREATHING CIRCUITS MARKET 157
TABLE 128 GERMANY: NUMBER OF SURGICAL PROCEDURES PERFORMED,
2011 VS. 2021 (PER 100,000 INHABITANTS) 158
TABLE 129 GERMANY: BREATHING CIRCUITS MARKET, BY USAGE, 2022–2029 (USD MILLION) 159
TABLE 130 GERMANY: BREATHING CIRCUITS MARKET, BY PATIENT TYPE,
2022–2029 (USD MILLION) 159
TABLE 131 GERMANY: BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE,
2022–2029 (USD MILLION) 159
TABLE 132 GERMANY: BREATHING CIRCUITS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 160
TABLE 133 GERMANY: BREATHING CIRCUITS MARKET, BY END USER,
2022–2029 (USD MILLION) 160
TABLE 134 FRANCE: NUMBER OF SURGICAL PROCEDURES PERFORMED,
2011 VS. 2021 (PER 100,000 INHABITANTS) 161
TABLE 135 FRANCE: BREATHING CIRCUITS MARKET, BY USAGE, 2022–2029 (USD MILLION) 161
TABLE 136 FRANCE: BREATHING CIRCUITS MARKET, BY PATIENT TYPE,
2022–2029 (USD MILLION) 162
TABLE 137 FRANCE: BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE,
2022–2029 (USD MILLION) 162
TABLE 138 FRANCE: BREATHING CIRCUITS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 162
TABLE 139 FRANCE: BREATHING CIRCUITS MARKET, BY END USER,
2022–2029 (USD MILLION) 163
TABLE 140 UK: BREATHING CIRCUITS MARKET, BY USAGE, 2022–2029 (USD MILLION) 164
TABLE 141 UK: BREATHING CIRCUITS MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION) 164
TABLE 142 UK: BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE, 2022–2029 (USD MILLION) 164
TABLE 143 UK: BREATHING CIRCUITS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 165
TABLE 144 UK: BREATHING CIRCUITS MARKET, BY END USER, 2022–2029 (USD MILLION) 165
TABLE 145 ITALY: NUMBER OF SURGICAL PROCEDURES PERFORMED,
2011 VS. 2021 (PER 100,000 INHABITANTS) 166
TABLE 146 ITALY: BREATHING CIRCUITS MARKET, BY USAGE, 2022–2029 (USD MILLION) 166
TABLE 147 ITALY: BREATHING CIRCUITS MARKET, BY PATIENT TYPE,
2022–2029 (USD MILLION) 167
TABLE 148 ITALY: BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE,
2022–2029 (USD MILLION) 167
TABLE 149 ITALY: BREATHING CIRCUITS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 167
TABLE 150 ITALY: BREATHING CIRCUITS MARKET, BY END USER, 2022–2029 (USD MILLION) 168
TABLE 151 SPAIN: NUMBER OF SURGICAL PROCEDURES PERFORMED,
2011 VS. 2021 (PER 100,000 INHABITANTS) 168
TABLE 152 SPAIN: BREATHING CIRCUITS MARKET, BY USAGE, 2022–2029 (USD MILLION) 169
TABLE 153 SPAIN: BREATHING CIRCUITS MARKET, BY PATIENT TYPE,
2022–2029 (USD MILLION) 169
TABLE 154 SPAIN: BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE,
2022–2029 (USD MILLION) 169
TABLE 155 SPAIN: BREATHING CIRCUITS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 170
TABLE 156 SPAIN: BREATHING CIRCUITS MARKET, BY END USER, 2022–2029 (USD MILLION) 170
TABLE 157 REST OF EUROPE: SELECTED HIGH-GROWTH PROCEDURES PERFORMED IN HOSPITALS, 2011 VS. 2021 (PER 100,000 INHABITANTS) 171
TABLE 158 REST OF EUROPE: BREATHING CIRCUITS MARKET, BY USAGE,
2022–2029 (USD MILLION) 171
TABLE 159 REST OF EUROPE: BREATHING CIRCUITS MARKET, BY PATIENT TYPE,
2022–2029 (USD MILLION) 171
TABLE 160 REST OF EUROPE: BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE,
2022–2029 (USD MILLION) 172
TABLE 161 REST OF EUROPE: BREATHING CIRCUITS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 172
TABLE 162 REST OF EUROPE: BREATHING CIRCUITS MARKET, BY END USER,
2022–2029 (USD MILLION) 172
TABLE 163 ASIA PACIFIC: BREATHING CIRCUITS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 175
TABLE 164 ASIA PACIFIC: BREATHING CIRCUITS MARKET, BY USAGE,
2022–2029 (USD MILLION) 175
TABLE 165 ASIA PACIFIC: BREATHING CIRCUITS MARKET, BY PATIENT TYPE,
2022–2029 (USD MILLION) 175
TABLE 166 ASIA PACIFIC: BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE,
2022–2029 (USD MILLION) 176
TABLE 167 ASIA PACIFIC: BREATHING CIRCUITS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 176
TABLE 168 ASIA PACIFIC: BREATHING CIRCUITS MARKET, BY END USER,
2022–2029 (USD MILLION) 176
TABLE 169 ASIA PACIFIC: MACROINDICATORS FOR BREATHING CIRCUITS MARKET 177
TABLE 170 JAPAN: BREATHING CIRCUITS MARKET, BY USAGE, 2022–2029 (USD MILLION) 178
TABLE 171 JAPAN: BREATHING CIRCUITS MARKET, BY PATIENT TYPE,
2022–2029 (USD MILLION) 179
TABLE 172 JAPAN: BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE,
2022–2029 (USD MILLION) 179
TABLE 173 JAPAN: BREATHING CIRCUITS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 179
TABLE 174 JAPAN: BREATHING CIRCUITS MARKET, BY END USER, 2022–2029 (USD MILLION) 180
TABLE 175 CHINA: BREATHING CIRCUITS MARKET, BY USAGE, 2022–2029 (USD MILLION) 181
TABLE 176 CHINA: BREATHING CIRCUITS MARKET, BY PATIENT TYPE,
2022–2029 (USD MILLION) 181
TABLE 177 CHINA: BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE,
2022–2029 (USD MILLION) 182
TABLE 178 CHINA: BREATHING CIRCUITS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 182
TABLE 179 CHINA: BREATHING CIRCUITS MARKET, BY END USER, 2022–2029 (USD MILLION) 182
TABLE 180 INDIA: BREATHING CIRCUITS MARKET, BY USAGE, 2022–2029 (USD MILLION) 184
TABLE 181 INDIA: BREATHING CIRCUITS MARKET, BY PATIENT TYPE,
2022–2029 (USD MILLION) 184
TABLE 182 INDIA: BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE,
2022–2029 (USD MILLION) 184
TABLE 183 INDIA: BREATHING CIRCUITS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 185
TABLE 184 INDIA: BREATHING CIRCUITS MARKET, BY END USER, 2022–2029 (USD MILLION) 185
TABLE 185 AUSTRALIA: BREATHING CIRCUITS MARKET, BY USAGE,
2022–2029 (USD MILLION) 186
TABLE 186 AUSTRALIA: BREATHING CIRCUITS MARKET, BY PATIENT TYPE,
2022–2029 (USD MILLION) 186
TABLE 187 AUSTRALIA: BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE,
2022–2029 (USD MILLION) 187
TABLE 188 AUSTRALIA: BREATHING CIRCUITS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 187
TABLE 189 AUSTRALIA: BREATHING CIRCUITS MARKET, BY END USER,
2022–2029 (USD MILLION) 187
TABLE 190 SOUTH KOREA: BREATHING CIRCUITS MARKET, BY USAGE,
2022–2029 (USD MILLION) 188
TABLE 191 SOUTH KOREA: BREATHING CIRCUITS MARKET, BY PATIENT TYPE,
2022–2029 (USD MILLION) 189
TABLE 192 SOUTH KOREA: BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE,
2022–2029 (USD MILLION) 189
TABLE 193 SOUTH KOREA: BREATHING CIRCUITS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 189
TABLE 194 SOUTH KOREA: BREATHING CIRCUITS MARKET, BY END USER,
2022–2029 (USD MILLION) 190
TABLE 195 REST OF ASIA PACIFIC: BREATHING CIRCUITS MARKET, BY USAGE,
2022–2029 (USD MILLION) 191
TABLE 196 REST OF ASIA PACIFIC: BREATHING CIRCUITS MARKET, BY PATIENT TYPE,
2022–2029 (USD MILLION) 191
TABLE 197 REST OF ASIA PACIFIC: BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE,
2022–2029 (USD MILLION) 191
TABLE 198 REST OF ASIA PACIFIC: BREATHING CIRCUITS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 192
TABLE 199 REST OF ASIA PACIFIC: BREATHING CIRCUITS MARKET, BY END USER,
2022–2029 (USD MILLION) 192
TABLE 200 LATIN AMERICA: BREATHING CIRCUITS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 193
TABLE 201 LATIN AMERICA: BREATHING CIRCUITS MARKET, BY USAGE,
2022–2029 (USD MILLION) 193
TABLE 202 LATIN AMERICA: BREATHING CIRCUITS MARKET, BY PATIENT TYPE,
2022–2029 (USD MILLION) 194
TABLE 203 LATIN AMERICA: BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE,
2022–2029 (USD MILLION) 194
TABLE 204 LATIN AMERICA: BREATHING CIRCUITS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 194
TABLE 205 LATIN AMERICA: BREATHING CIRCUITS MARKET, BY END USER,
2022–2029 (USD MILLION) 195
TABLE 206 LATIN AMERICA: MACROINDICATORS FOR BREATHING CIRCUITS MARKET 195
TABLE 207 BRAZIL: BREATHING CIRCUITS MARKET, BY USAGE, 2022–2029 (USD MILLION) 196
TABLE 208 BRAZIL: BREATHING CIRCUITS MARKET, BY PATIENT TYPE,
2022–2029 (USD MILLION) 197
TABLE 209 BRAZIL: BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE,
2022–2029 (USD MILLION) 197
TABLE 210 BRAZIL: BREATHING CIRCUITS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 197
TABLE 211 BRAZIL: BREATHING CIRCUITS MARKET, BY END USER,
2022–2029 (USD MILLION) 198
TABLE 212 MEXICO: BREATHING CIRCUITS MARKET, BY USAGE, 2022–2029 (USD MILLION) 199
TABLE 213 MEXICO: BREATHING CIRCUITS MARKET, BY PATIENT TYPE,
2022–2029 (USD MILLION) 199
TABLE 214 MEXICO: BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE,
2022–2029 (USD MILLION) 199
TABLE 215 MEXICO: BREATHING CIRCUITS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 200
TABLE 216 MEXICO: BREATHING CIRCUITS MARKET, BY END USER,
2022–2029 (USD MILLION) 200
TABLE 217 REST OF LATIN AMERICA: BREATHING CIRCUITS MARKET, BY USAGE,
2022–2029 (USD MILLION) 201
TABLE 218 REST OF LATIN AMERICA: BREATHING CIRCUITS MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION) 201
TABLE 219 REST OF LATIN AMERICA: BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE,
2022–2029 (USD MILLION) 201
TABLE 220 REST OF LATIN AMERICA: BREATHING CIRCUITS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 202
TABLE 221 REST OF LATIN AMERICA: BREATHING CIRCUITS MARKET, BY END USER,
2022–2029 (USD MILLION) 202
TABLE 222 MIDDLE EAST & AFRICA: BREATHING CIRCUITS MARKET, BY USAGE,
2022–2029 (USD MILLION) 203
TABLE 223 MIDDLE EAST & AFRICA: BREATHING CIRCUITS MARKET, BY PATIENT TYPE,
2022–2029 (USD MILLION) 204
TABLE 224 MIDDLE EAST & AFRICA: BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE,
2022–2029 (USD MILLION) 204
TABLE 225 MIDDLE EAST & AFRICA: BREATHING CIRCUITS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 204
TABLE 226 MIDDLE EAST & AFRICA: BREATHING CIRCUITS MARKET, BY END USER,
2022–2029 (USD MILLION) 205
TABLE 227 GCC COUNTRIES: BREATHING CIRCUITS MARKET, BY USAGE,
2022–2029 (USD MILLION) 206
TABLE 228 GCC COUNTRIES: BREATHING CIRCUITS MARKET, BY PATIENT TYPE,
2022–2029 (USD MILLION) 206
TABLE 229 GCC COUNTRIES: BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE,
2022–2029 (USD MILLION) 207
TABLE 230 GCC COUNTRIES: BREATHING CIRCUITS MARKET, BY APPLICATION,
2022–2029 (USD MILLION) 207
TABLE 231 GCC COUNTRIES: BREATHING CIRCUITS MARKET, BY END USER,
2022–2029 (USD MILLION) 207
TABLE 232 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN BREATHING CIRCUITS MARKET 209
TABLE 233 BREATHING CIRCUITS MARKET: DEGREE OF COMPETITION 212
TABLE 234 BREATHING CIRCUITS MARKET: USAGE FOOTPRINT 216
TABLE 235 BREATHING CIRCUITS MARKET: APPLICATION FOOTPRINT 217
TABLE 236 BREATHING CIRCUITS MARKET: REGION FOOTPRINT 218
TABLE 237 BREATHING CIRCUITS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 220
TABLE 238 BREATHING CIRCUITS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 220
TABLE 239 BREATHING CIRCUITS MARKET: PRODUCT LAUNCHES, JANUARY 2021– JULY 2024 223
TABLE 240 BREATHING CIRCUITS MARKET: DEALS, JANUARY 2021– JULY 2024 224
TABLE 241 DRÄGERWERK AG & CO. KGAA: COMPANY OVERVIEW 225
TABLE 242 DRÄGERWERK AG & CO. KGAA: PRODUCTS OFFERED 227
TABLE 243 DRÄGERWERK AG & CO. KGAA: PRODUCT LAUNCHES, JANUARY 2021–JULY 2024 228
TABLE 244 DRÄGERWERK AG & CO. KGAA: DEALS, JANUARY 2021–JULY 2024 228
TABLE 245 MEDTRONIC: COMPANY OVERVIEW 230
TABLE 246 MEDTRONIC: PRODUCTS OFFERED 231
TABLE 247 MEDTRONIC: DEALS, JANUARY 2021–JULY 2024 232
TABLE 248 CARDINAL HEALTH.: COMPANY OVERVIEW 234
TABLE 249 CARDINAL HEALTH: PRODUCTS OFFERED 235
TABLE 250 CARDINAL HEALTH: EXPANSIONS, JANUARY 2021–JULY 2024 236
TABLE 251 FISHER & PAYKEL HEALTHCARE LIMITED: COMPANY OVERVIEW 238
TABLE 252 FISHER & PAYKEL HEALTHCARE LIMITED: PRODUCTS OFFERED 239
TABLE 253 FISHER & PAYKEL HEALTHCARE LIMITED: EXPANSIONS,
JANUARY 2021–JULY 2024 240
TABLE 254 RESMED: COMPANY OVERVIEW 241
TABLE 255 RESMED: PRODUCTS OFFERED 242
TABLE 256 RESMED: EXPANSIONS, JANUARY 2021–JULY 2024 243
TABLE 257 AMBU A/S: COMPANY OVERVIEW 244
TABLE 258 AMBU A/S: PRODUCTS OFFERED 246
TABLE 259 AMBU A/S: EXPANSIONS, JANUARY 2021–JULY 2024 246
TABLE 260 GE HEALTHCARE: COMPANY OVERVIEW 247
TABLE 261 GE HEALTHCARE: PRODUCTS OFFERED 248
TABLE 262 GE HEALTHCARE: DEALS, JANUARY 2021–JULY 2024 249
TABLE 263 GE HEALTHCARE: EXPANSIONS, JANUARY 2021–JULY 2024 249
TABLE 264 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 250
TABLE 265 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED 251
TABLE 266 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2021–JULY 2024 252
TABLE 267 ICU MEDICAL, INC.: COMPANY OVERVIEW 253
TABLE 268 ICU MEDICAL, INC.: PRODUCTS OFFERED 255
TABLE 269 ICU MEDICAL, INC.: DEALS, JANUARY 2021–JULY 2024 255
TABLE 270 HAMILTON MEDICAL: COMPANY OVERVIEW 256
TABLE 271 HAMILTON MEDICAL: PRODUCTS OFFERED 256
TABLE 272 MEDLINE INDUSTRIES, LP: COMPANY OVERVIEW 257
TABLE 273 MEDLINE INDUSTRIES, LP: PRODUCTS OFFERED 257
TABLE 274 MEDLINE INDUSTRIES, LP: DEALS, JANUARY 2021–JULY 2024 258
TABLE 275 MEDLINE INDUSTRIES, LP: EXPANSIONS, JANUARY 2021–JULY 2024 259
TABLE 276 FORCA HEALTHCARE: COMPANY OVERVIEW 260
TABLE 277 BRAUN & CO. LIMITED: COMPANY OVERVIEW 261
TABLE 278 INSPIRATION HEALTHCARE GROUP PLC: COMPANY OVERVIEW 262
TABLE 279 BESMED HEALTH BUSINESS CORP.: COMPANY OVERVIEW 263
TABLE 280 EAKIN HEALTHCARE: COMPANY OVERVIEW 264
TABLE 281 BOMIMED: COMPANY OVERVIEW 265
TABLE 282 FLEXICARE (GROUP) LIMITED: COMPANY OVERVIEW 266
TABLE 283 BIO-MED DEVICES: COMPANY OVERVIEW 267
TABLE 284 AIRLIFE: COMPANY OVERVIEW 268
TABLE 285 MERCURY MEDICAL: COMPANY OVERVIEW 269
TABLE 286 INTERSURGICAL LTD.: COMPANY OVERVIEW 270
TABLE 287 FAIRMONT MEDICAL PRODUCTS PTY LTD.: COMPANY OVERVIEW 271
TABLE 288 BREAS MEDICAL AB: COMPANY OVERVIEW 272
TABLE 289 GPC MEDICAL LTD.: COMPANY OVERVIEW 273
LIST OF FIGURES
FIGURE 1 BREATHING CIRCUITS MARKET: SEGMENTS CONSIDERED 27
FIGURE 2 BREATHING CIRCUITS MARKET: YEARS CONSIDERED 28
FIGURE 3 BREATHING CIRCUITS MARKET: RESEARCH DESIGN 30
FIGURE 4 BREATHING CIRCUITS MARKET: KEY DATA FROM SECONDARY SOURCES 32
FIGURE 5 BREATHING CIRCUITS MARKET: KEY PRIMARY SOURCES 33
FIGURE 6 BREATHING CIRCUITS MARKET: KEY INDUSTRY INSIGHTS 35
FIGURE 7 BREAKDOWN OF PRIMARIES: SUPPLY- AND DEMAND-SIDE PARTICIPANTS 35
FIGURE 8 BREAKDOWN OF PRIMARIES: BY COMPANY TYPE, DESIGNATION, AND REGION 36
FIGURE 9 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 37
FIGURE 10 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 38
FIGURE 11 BREATHING CIRCUITS MARKET: TOP-DOWN APPROACH 39
FIGURE 12 DATA TRIANGULATION METHODOLOGY 40
FIGURE 13 BREATHING CIRCUITS MARKET: STUDY ASSUMPTIONS 41
FIGURE 14 BREATHING CIRCUITS MARKET, BY USAGE, 2024 VS. 2029 (USD MILLION) 43
FIGURE 15 BREATHING CIRCUITS MARKET, BY PATIENT TYPE, 2024 VS. 2029 (USD MILLION) 44
FIGURE 16 BREATHING CIRCUITS MARKET, BY CIRCUIT TYPE, 2024 VS. 2029 (USD MILLION) 44
FIGURE 17 BREATHING CIRCUITS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION) 45
FIGURE 18 BREATHING CIRCUITS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION) 46
FIGURE 19 BREATHING CIRCUITS MARKET, BY REGION, 2024 VS. 2029 (USD MILLION) 46
FIGURE 20 INCREASING NUMBER OF SURGERIES AND GROWING PREVALENCE OF
CHRONIC RESPIRATORY DISORDERS TO DRIVE MARKET 48
FIGURE 21 DISPOSABLE BREATHING CIRCUITS TO DOMINATE BREATHING CIRCUITS USAGE MARKET IN 2029 48
FIGURE 22 ADULT PATIENTS SEGMENT TO COMMAND LARGER MARKET SHARE DURING FORECAST PERIOD 49
FIGURE 23 SINGLE-LIMB BREATHING CIRCUITS TO ACCOUNT FOR LARGER MARKET SHARE BETWEEN 2024 AND 2029 49
FIGURE 24 ANESTHESIA TO COMMAND LARGEST SHARE IN BREATHING CIRCUITS APPLICATION MARKET DURING STUDY PERIOD 50
FIGURE 25 HOSPITALS TO DOMINATE END USER MARKET DURING FORECAST PERIOD 50
FIGURE 26 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 51
FIGURE 27 BREATHING CIRCUITS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 52
FIGURE 28 US: NUMBER OF HOSPITAL EMERGENCY ROOM VISITS,
2012–2022 (PER 1,000 POPULATION) 54
FIGURE 29 AVERAGE SELLING PRICE OF SINGLE-LIMB BREATHING CIRCUITS (2024) 61
FIGURE 30 PATENT ANALYSIS FOR BREATHING CIRCUITS (JANUARY 2014– DECEMBER 2023) 62
FIGURE 31 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES 64
FIGURE 32 BREATHING CIRCUITS MARKET: SUPPLY CHAIN ANALYSIS 65
FIGURE 33 BREATHING CIRCUITS MARKET: ECOSYSTEM ANALYSIS 68
FIGURE 34 BREATHING CIRCUITS MARKET: PORTER’S FIVE FORCES ANALYSIS 69
FIGURE 35 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF BREATHING CIRCUITS 71
FIGURE 36 KEY BUYING CRITERIA FOR BREATHING CIRCUITS 72
FIGURE 37 BREATHING CIRCUITS MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS 82
FIGURE 38 NUMBER OF DEALS AND FUNDING IN BREATHING CIRCUITS MARKET 83
FIGURE 39 MARKET POTENTIAL OF AI TO ENHANCE USE OF BREATHING CIRCUITS ACROSS CLINICAL SETTINGS 84
FIGURE 40 US: AGE-ADJUSTED PREVALENCE OF COPD AMONG ADULTS AGED ≥18 YEARS (2011 VS. 2021) 98
FIGURE 41 NORTH AMERICA: BREATHING CIRCUITS MARKET SNAPSHOT 145
FIGURE 42 ASIA PACIFIC: BREATHING CIRCUITS MARKET SNAPSHOT 174
FIGURE 43 REVENUE ANALYSIS OF KEY PLAYERS IN BREATHING CIRCUITS MARKET
(2021–2023) 211
FIGURE 44 MARKET SHARE ANALYSIS OF KEY PLAYERS IN BREATHING CIRCUITS MARKET (2023) 212
FIGURE 45 BREATHING CIRCUITS MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2023 215
FIGURE 46 BREATHING CIRCUITS MARKET: COMPANY FOOTPRINT 216
FIGURE 47 BREATHING CIRCUITS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 219
FIGURE 48 EV/EBITDA OF KEY VENDORS 221
FIGURE 49 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 221
FIGURE 50 BREATHING CIRCUITS MARKET: PRODUCT ANALYSIS FOR DUAL-LIMB BREATHING CIRCUITS 222
FIGURE 51 DRÄGERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2023) 226
FIGURE 52 MEDTRONIC: COMPANY SNAPSHOT (2023) 231
FIGURE 53 CARDINAL HEALTH: COMPANY SNAPSHOT (2023) 235
FIGURE 54 FISHER & PAYKEL HEALTHCARE LIMITED: COMPANY SNAPSHOT (2023) 239
FIGURE 55 RESMED: COMPANY SNAPSHOT (2023) 242
FIGURE 56 AMBU A/S: COMPANY SNAPSHOT (2023) 245
FIGURE 57 GE HEALTHCARE: COMPANY SNAPSHOT (2023) 248
FIGURE 58 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2023) 251
FIGURE 59 ICU MEDICAL, INC.: COMPANY SNAPSHOT (2023) 254
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11